You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
先健科技(01302.HK)配售融資逾9億港元
格隆匯 12-07 17:56

2020年12月4日,領先的心腦血管和外周血管微創介入醫療器械企業——先健科技公司(以下簡稱“先健科技”或“公司”)與Citigroup Global Markets Limited(“花旗”)簽署配售協議(“配售協議”),將以每股3.2368港元的價格配售287,320,000股公司新股(以下稱“本次配售”)。本次配售及認購股份數額為先健科技配售前已發行股本的約6.62%及配售完成後擴大股本的約6.21%。本次配售如獲悉數完成,公司將錄得約9.3億港元的融資金額。

於2020年12月7日,根據公司獲悉的相關權益披露資料,高瓴作為先健科技重要的戰略投資者之一亦通過本次配售增持166,260,000股公司股票。本次配售完成後,高瓴在先健科技的持股數量達428,738,000股,持股比例由6.05%升至9.88%。

本次配售的順利推進彰顯了資本市場對先健科技綜合實力及企業價值的認可。公司將高效、合理利用配售募集資金,為持續創新發展注入新動力,快速推動各創新管線的研發、臨牀和產品的全球市場準入進程,在不斷豐富創新產品組合的同時進一步深化公司的國際化佈局,併為公司後續新的發展機會和業務領域拓展奠定資金基礎。

先健科技成立至今始終堅持以創新為公司的核心發展力。截止目前,先健科技已在全球範圍內實現超過1000項專利佈局,並在心腦血管和外周血管等多個細分領域實現技術突破,為全球超過100個國家和地區的醫生和患者帶來了安全有效的創新介入解決方案。未來,先健科技將藉助資本的力量,實現長期可持續發展,為各相關方創造更大價值。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account